Pharmaceutical Startups in Türkiye and Turkish Republic of Northern Cyprus (TRNC): A SWOT Analysis Inspired by the WEF Future of Jobs Report 2025
Solmaz Hazratgholizad, Peyman Keyhanvar, Soodabeh Davaran
EMU Journal of Pharmaceutical Sciences·2025
This study conducts a SWOT analysis of pharmaceutical startups in Türkiye and the Turkish Republic of Northern Cyprus (TRNC), informed by the World Economic Forum’s Future of Jobs Report 2025. Employing a qualitative, expert-driven approach with secondary data from peer-reviewed articles, industry reports, and innovation indices (2018–2025), the research utilizes a 30-point SWOT matrix to evaluate internal strengths (e.g., Türkiye’s industrial base, TRNC’s EU-funded initiatives), weaknesses (e.g., regulatory hurdles, limited AI talent), external opportunities (e.g., AI-driven R&D, green manufacturing), and threats (e.g., geopolitical instability, trade barriers). Türkiye’s robust ecosystem supports an offensive strategy, leveraging generic drug production, precision medicine, and digital health to compete in MENA and EU markets. Conversely, TRNC’s smaller, geopolitically constrained ecosystem favors a conservative approach, focusing on niche markets like orphan drugs and clinical trial hosting through alignment with Türkiye. Strategic frameworks propose short-, medium-, and long-term priorities, including regulatory acceleration and AI talent development, to enhance competitiveness. Despite relying on secondary data and excluding the Republic of Cyprus, this study bridges entrepreneurship and global foresight, offering actionable insights for stakeholders to foster innovation and economic growth. Future research should incorporate primary stakeholder perspectives and broader regional analyses.